Prospective study | |||||
---|---|---|---|---|---|
Characteristic | Comparative study | Cross sectional study | Crohn's disease | Irritable bowel syndrome | Miscellaneous diagnosis |
n | 22 | 112 | 31 | 159 | 30 |
Sex (M/F) | 12/10 | 62/50 | 13/18 | 38/121 | 12/18 |
Age (y) | 49 (32–75) | 34 (18–77) | 30 (16–72) | 39 (16–85) | 60 (21–85)1-150 |
Disease site | |||||
Small bowel | 2 | 14 | 1 | ||
Ileum | 13 | 43 | 14 | ||
Ileocaecal±colon | 4 | 34 | 11 | ||
Colon | 3 | 21 | 5 | ||
Prior resections (%) | 8 (37) | 49 (44) | |||
Duration of disease (y) | 8 (1–22) | 11 (0.5–36) | |||
Treatment | |||||
Prednisolone | 3 | 27 | |||
Sulphasalazine | 3 | 9 | |||
5-aminosalicylic acid | 3 | 46 | |||
Azothioprine | 0 | 33 |
Values for age and duration of disease are mean (range).
↵1-150 Significantly different (p<0.0002) from patients with Crohn's disease and irritable bowel syndrome.